Candidate for the Lee B. Lusted Student Prize Competition
Purpose:
For cost-effectiveness analyses (CEA) that use observational data the key methodological challenge is to minimize selection bias. Propensity score (Pscore) methods can reduce selection bias due to observable differences between treatment groups; but the true Pscore model is generally unknown. Doubly robust (DR) methods exploit information in the Pscore and the response models, and provide unbiased estimates if either model is correctly specified. These methods hold promise for CEA, where selection bias needs to be minimized for the cost as well as the effectiveness endpoint. DR methods have not been examined before in this context.Method:
To compare the methods in a CEA, we evaluate Drotrecogin alfa activated (DrotAA), a pharmaceutical intervention for critically ill patients with severe sepsis. We use data from a published observational study (n=1,898). Potential confounders were selected a priori (e.g. age, APACHE II severity score). Higher order terms and interaction terms were considered, and regression models for both cost and effectiveness were selected by cross-validation. A two-part model was chosen for the QALY and a generalized linear model with gamma distribution for the costs. To maintain correlation between costs and effects, confidence intervals (CI) were constructed by nonparametric bootstrapping.
Result: Conclusion:
See more of: The 33rd Annual Meeting of the Society for Medical Decision Making